FDA Import Refusal 799-3142994-8/21/2 — Windlas Healthcare Private Limited
The FDA refused shipment 799-3142994-8/21/2 from Windlas Healthcare Private Limited (India) on February 9, 2023. The refused product falls under Drugs and Biologics — METFORMIN (ANTI-DIABETIC). Cited charges: 118,27,75 This firm has 4 other import refusals on record.
Refusal Details
- Date
- February 9, 2023
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY26 METFORMIN (ANTI-DIABETIC)
- Charges
- 118,27,75